drugset / Trial / NCT02251600
A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy
NaSingle-groupOpen-labelBasic science
Summary
Study to characterize the single-state and steady-state dosing of oral deflazacort in pediatric and adolescents subjects.
Timeline
- Start
- 2014-12
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Deflazacort | Other / unclassified | 0.9 mg/kg | Oral |